Vitro, S.A.B. de C.V. Logo

Vitro, S.A.B. de C.V.

VITROA.MX

(1.8)
Stock Price

8,70 MXN

2.31% ROA

4.58% ROE

9.01x PER

Market Cap.

501.664.864,33 MXN

67.46% DER

0% Yield

2.32% NPM

Vitro, S.A.B. de C.V. Stock Analysis

Vitro, S.A.B. de C.V. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Vitro, S.A.B. de C.V. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.44x), the stock offers substantial upside potential at a bargain price.

2 ROE

ROE in an average range (2.15%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (1.08%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 DER

The stock has a reasonable amount of debt compared to its ownership (71%), suggesting a balanced financial position and a moderate level of risk.

5 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (40), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Vitro, S.A.B. de C.V. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Vitro, S.A.B. de C.V. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Vitro, S.A.B. de C.V. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Vitro, S.A.B. de C.V. Revenue
Year Revenue Growth
1993 3.519.200.000
1994 2.872.500.000 -22.51%
1995 2.841.000.000 -1.11%
1996 2.236.000.000 -27.06%
1997 2.525.000.000 11.45%
1998 2.510.000.000 -0.6%
1999 2.725.000.000 7.89%
2000 2.914.000.000 6.49%
2001 3.078.000.000 5.33%
2002 2.303.000.000 -33.65%
2003 2.223.000.000 -3.6%
2004 2.348.000.000 5.32%
2005 2.271.000.000 -3.39%
2006 2.457.000.000 7.57%
2007 2.631.000.000 6.61%
2008 2.109.116.022 -24.74%
2009 1.833.613.574 -15.03%
2010 1.895.536.670 3.27%
2011 1.568.347.184 -20.86%
2012 1.800.378.584 12.89%
2013 1.653.296.037 -8.9%
2014 1.530.053.977 -8.05%
2015 818.019.475 -87.04%
2016 957.602.904 14.58%
2017 1.983.095.723 51.71%
2018 2.238.379.000 11.4%
2019 2.180.256.000 -2.67%
2020 1.768.299.000 -23.3%
2021 1.957.568.000 9.67%
2022 2.352.362.000 16.78%
2023 2.502.628.000 6%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Vitro, S.A.B. de C.V. Research and Development Expenses
Year Research and Development Expenses Growth
1993 0
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Vitro, S.A.B. de C.V. General and Administrative Expenses
Year General and Administrative Expenses Growth
1993 626.700.000
1994 508.100.000 -23.34%
1995 467.700.000 -8.64%
1996 498.000.000 6.08%
1997 530.000.000 6.04%
1998 536.000.000 1.12%
1999 432.000.000 -24.07%
2000 494.000.000 12.55%
2001 540.000.000 8.52%
2002 475.000.000 -13.68%
2003 451.000.000 -5.32%
2004 479.000.000 5.85%
2005 478.000.000 -0.21%
2006 492.000.000 2.85%
2007 524.000.000 6.11%
2008 437.917.999 -19.66%
2009 418.985.020 -4.52%
2010 0 0%
2011 0 0%
2012 160.391.983 100%
2013 135.561.371 -18.32%
2014 118.244.711 -14.64%
2015 78.287.133 -51.04%
2016 75.584.987 -3.57%
2017 164.052.953 53.93%
2018 165.261.000 0.73%
2019 145.540.000 -13.55%
2020 15.407.000 -844.64%
2021 45.235.000 65.94%
2022 55.789.000 18.92%
2023 153.228.000 63.59%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Vitro, S.A.B. de C.V. EBITDA
Year EBITDA Growth
1993 647.700.000
1994 451.200.000 -43.55%
1995 592.400.000 23.84%
1996 537.000.000 -10.32%
1997 601.000.000 10.65%
1998 603.000.000 0.33%
1999 611.000.000 1.31%
2000 567.000.000 -7.76%
2001 583.000.000 2.74%
2002 381.000.000 -53.02%
2003 362.000.000 -5.25%
2004 354.000.000 -2.26%
2005 393.000.000 9.92%
2006 363.000.000 -8.26%
2007 242.000.000 -50%
2008 -341.451.003 170.87%
2009 75.206.359 554.02%
2010 199.082.033 62.22%
2011 257.716.038 22.75%
2012 241.951.189 -6.52%
2013 318.024.212 23.92%
2014 198.273.709 -60.4%
2015 103.128.243 -92.26%
2016 263.051.201 60.8%
2017 407.230.143 35.4%
2018 372.839.000 -9.22%
2019 269.053.000 -38.57%
2020 213.696.000 -25.9%
2021 133.536.000 -60.03%
2022 215.021.000 37.9%
2023 88.156.000 -143.91%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Vitro, S.A.B. de C.V. Gross Profit
Year Gross Profit Growth
1993 1.274.400.000
1994 959.300.000 -32.85%
1995 1.060.100.000 9.51%
1996 1.035.000.000 -2.43%
1997 1.131.000.000 8.49%
1998 1.139.000.000 0.7%
1999 1.043.000.000 -9.2%
2000 1.056.000.000 1.23%
2001 824.000.000 -28.16%
2002 667.000.000 -23.54%
2003 616.000.000 -8.28%
2004 620.000.000 0.65%
2005 630.000.000 1.59%
2006 673.000.000 6.39%
2007 773.000.000 12.94%
2008 562.227.392 -37.49%
2009 520.483.033 -8.02%
2010 500.178.403 -4.06%
2011 473.772.293 -5.57%
2012 487.251.992 2.77%
2013 480.912.790 -1.32%
2014 434.763.130 -10.61%
2015 270.878.113 -60.5%
2016 345.827.863 21.67%
2017 603.207.739 42.67%
2018 623.861.000 3.31%
2019 524.823.000 -18.87%
2020 366.710.000 -43.12%
2021 396.006.000 7.4%
2022 520.547.000 23.93%
2023 592.720.000 12.18%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Vitro, S.A.B. de C.V. Net Profit
Year Net Profit Growth
1993 224.800.000
1994 -220.200.000 202.09%
1995 108.600.000 302.76%
1996 -523.000.000 120.76%
1997 339.000.000 254.28%
1998 -25.000.000 1456%
1999 68.000.000 136.76%
2000 35.000.000 -94.29%
2001 15.000.000 -133.33%
2002 -4.000.000 475%
2003 -34.000.000 88.24%
2004 -4.000.000 -750%
2005 4.000.000 200%
2006 24.000.000 83.33%
2007 12.000.000 -100%
2008 -413.056.121 102.91%
2009 -63.359.829 -551.92%
2010 -97.148.788 34.78%
2011 27.581.650 452.22%
2012 206.507.599 86.64%
2013 44.675.378 -362.24%
2014 -3.869.086 1254.68%
2015 1.366.550.548 100.28%
2016 174.627.384 -682.55%
2017 186.761.711 6.5%
2018 161.739.000 -15.47%
2019 64.113.000 -152.27%
2020 -45.376.000 241.29%
2021 -106.601.000 57.43%
2022 17.864.000 696.74%
2023 57.400.000 68.88%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Vitro, S.A.B. de C.V. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1993 1
1994 -1 0%
1995 0 0%
1996 -1 100%
1997 1 200%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 -1 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 3 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Vitro, S.A.B. de C.V. Free Cashflow
Year Free Cashflow Growth
1993 -9.000.000
1994 -19.000.000 52.63%
1995 50.300.000 137.77%
1996 114.000.000 55.88%
1997 368.000.000 69.02%
1998 75.000.000 -390.67%
1999 287.000.000 73.87%
2000 260.000.000 -10.38%
2001 323.000.000 19.5%
2002 85.000.000 -280%
2003 -36.000.000 336.11%
2004 37.000.000 197.3%
2005 84.000.000 55.95%
2006 -16.000.000 625%
2007 -82.000.000 80.49%
2008 55.757.488 247.07%
2009 228.294.100 75.58%
2010 89.769.373 -154.31%
2011 118.586.728 24.3%
2012 164.520.577 27.92%
2013 164.730.862 0.13%
2014 157.750.119 -4.43%
2015 214.826.379 26.57%
2016 155.031.277 -38.57%
2017 122.912.424 -26.13%
2018 51.130.000 -140.39%
2019 121.515.000 57.92%
2020 119.400.000 -1.77%
2021 -125.772.000 194.93%
2022 105.102.000 219.67%
2023 -29.636.000 454.64%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Vitro, S.A.B. de C.V. Operating Cashflow
Year Operating Cashflow Growth
1993 283.400.000
1994 188.300.000 -50.5%
1995 285.600.000 34.07%
1996 296.000.000 3.51%
1997 541.000.000 45.29%
1998 306.000.000 -76.8%
1999 461.000.000 33.62%
2000 372.000.000 -23.92%
2001 426.000.000 12.68%
2002 183.000.000 -132.79%
2003 122.000.000 -50%
2004 167.000.000 26.95%
2005 180.000.000 7.22%
2006 95.000.000 -89.47%
2007 166.000.000 42.77%
2008 186.464.088 10.97%
2009 305.411.189 38.95%
2010 171.997.146 -77.57%
2011 210.669.214 18.36%
2012 245.067.109 14.04%
2013 307.124.034 20.21%
2014 257.396.064 -19.32%
2015 295.719.223 12.96%
2016 269.470.615 -9.74%
2017 282.892.057 4.74%
2018 222.495.000 -27.15%
2019 289.369.000 23.11%
2020 223.695.000 -29.36%
2021 -24.899.000 998.41%
2022 274.620.000 109.07%
2023 21.467.000 -1179.27%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Vitro, S.A.B. de C.V. Capital Expenditure
Year Capital Expenditure Growth
1993 292.400.000
1994 207.300.000 -41.05%
1995 235.300.000 11.9%
1996 182.000.000 -29.29%
1997 173.000.000 -5.2%
1998 231.000.000 25.11%
1999 174.000.000 -32.76%
2000 112.000.000 -55.36%
2001 103.000.000 -8.74%
2002 98.000.000 -5.1%
2003 158.000.000 37.97%
2004 130.000.000 -21.54%
2005 96.000.000 -35.42%
2006 111.000.000 13.51%
2007 248.000.000 55.24%
2008 130.706.601 -89.74%
2009 77.117.090 -69.49%
2010 82.227.773 6.22%
2011 92.082.486 10.7%
2012 80.546.532 -14.32%
2013 142.393.172 43.43%
2014 99.645.945 -42.9%
2015 80.892.844 -23.18%
2016 114.439.339 29.31%
2017 159.979.633 28.47%
2018 171.365.000 6.64%
2019 167.854.000 -2.09%
2020 104.295.000 -60.94%
2021 100.873.000 -3.39%
2022 169.518.000 40.49%
2023 51.103.000 -231.72%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Vitro, S.A.B. de C.V. Equity
Year Equity Growth
1993 2.096.600.000
1994 1.468.600.000 -42.76%
1995 1.432.500.000 -2.52%
1996 825.000.000 -73.64%
1997 973.000.000 15.21%
1998 722.000.000 -34.76%
1999 767.000.000 5.87%
2000 635.000.000 -20.79%
2001 604.000.000 -5.13%
2002 572.000.000 -5.59%
2003 515.000.000 -11.07%
2004 480.000.000 -7.29%
2005 516.000.000 6.98%
2006 660.000.000 21.82%
2007 684.000.000 3.51%
2008 0 0%
2009 370.000.000 100%
2010 -9.778.000.000 103.78%
2011 -5.961.659 -163914.78%
2012 303.412.711 101.96%
2013 391.408.510 22.48%
2014 458.045.528 14.55%
2015 1.082.354.358 57.68%
2016 1.192.080.470 9.2%
2017 1.385.743.381 13.98%
2018 1.468.263.000 5.62%
2019 1.430.276.000 -2.66%
2020 1.304.913.000 -9.61%
2021 1.200.405.000 -8.71%
2022 1.205.916.000 0.46%
2023 1.263.696.000 4.57%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Vitro, S.A.B. de C.V. Assets
Year Assets Growth
1993 5.478.600.000
1994 4.338.300.000 -26.28%
1995 4.487.000.000 3.31%
1996 3.386.000.000 -32.52%
1997 3.382.000.000 -0.12%
1998 3.117.000.000 -8.5%
1999 3.294.000.000 5.37%
2000 3.339.000.000 1.35%
2001 3.423.000.000 2.45%
2002 2.889.000.000 -18.48%
2003 2.751.000.000 -5.02%
2004 2.801.000.000 1.79%
2005 2.827.000.000 0.92%
2006 2.507.000.000 -12.76%
2007 2.962.000.000 15.36%
2008 0 0%
2009 0 0%
2010 0 0%
2011 2.398.095.142 100%
2012 2.732.194.465 12.23%
2013 2.566.454.625 -6.46%
2014 2.379.623.898 -7.85%
2015 1.605.812.704 -48.19%
2016 2.192.785.157 26.77%
2017 2.678.462.322 18.13%
2018 2.770.890.000 3.34%
2019 2.793.833.000 0.82%
2020 2.893.032.000 3.43%
2021 2.539.322.000 -13.93%
2022 2.558.225.000 0.74%
2023 2.725.864.000 6.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Vitro, S.A.B. de C.V. Liabilities
Year Liabilities Growth
1993 3.100.800.000
1994 2.672.300.000 -16.03%
1995 2.759.000.000 3.14%
1996 2.198.000.000 -25.52%
1997 2.010.000.000 -9.35%
1998 2.025.000.000 0.74%
1999 2.111.000.000 4.07%
2000 2.377.000.000 11.19%
2001 2.455.000.000 3.18%
2002 2.061.000.000 -19.12%
2003 1.980.000.000 -4.09%
2004 2.070.000.000 4.35%
2005 2.045.000.000 -1.22%
2006 1.686.000.000 -21.29%
2007 2.098.000.000 19.64%
2008 0 0%
2009 0 0%
2010 0 0%
2011 2.310.034.980 100%
2012 2.331.175.559 0.91%
2013 2.076.176.893 -12.28%
2014 1.831.639.081 -13.35%
2015 439.380.744 -316.87%
2016 999.835.895 56.05%
2017 1.291.751.527 22.6%
2018 1.302.627.000 0.83%
2019 1.363.557.000 4.47%
2020 1.588.119.000 14.14%
2021 1.338.917.000 -18.61%
2022 1.352.309.000 0.99%
2023 1.462.168.000 7.51%

Vitro, S.A.B. de C.V. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.11
Net Income per Share
0.12
Price to Earning Ratio
9.01x
Price To Sales Ratio
0.21x
POCF Ratio
2.35
PFCF Ratio
8.66
Price to Book Ratio
0.4
EV to Sales
0.5
EV Over EBITDA
6
EV to Operating CashFlow
5.59
EV to FreeCashFlow
20.94
Earnings Yield
0.11
FreeCashFlow Yield
0.12
Market Cap
0,50 Bil.
Enterprise Value
1,21 Bil.
Graham Number
2.65
Graham NetNet
-2.24

Income Statement Metrics

Net Income per Share
0.12
Income Quality
8.26
ROE
0.05
Return On Assets
0.02
Return On Capital Employed
0.06
Net Income per EBT
0.75
EBT Per Ebit
0.6
Ebit per Revenue
0.05
Effective Tax Rate
-0.22

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.24
Operating Profit Margin
0.05
Pretax Profit Margin
0.03
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.45
Free CashFlow per Share
0.12
Capex to Operating CashFlow
-0.73
Capex to Revenue
-0.07
Capex to Depreciation
-1.44
Return on Invested Capital
0.07
Return on Tangible Assets
0.02
Days Sales Outstanding
0
Days Payables Outstanding
51.56
Days of Inventory on Hand
97.85
Receivables Turnover
0
Payables Turnover
7.08
Inventory Turnover
3.73
Capex per Share
-0.33

Balance Sheet

Cash per Share
0,29
Book Value per Share
2,64
Tangible Book Value per Share
2.07
Shareholders Equity per Share
2.64
Interest Debt per Share
1.89
Debt to Equity
0.67
Debt to Assets
0.31
Net Debt to EBITDA
3.52
Current Ratio
1.55
Tangible Asset Value
0,99 Bil.
Net Current Asset Value
-0,55 Bil.
Invested Capital
0.67
Working Capital
0,33 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,05 Bil.
Average Payables
0,27 Bil.
Average Inventory
507724000
Debt to Market Cap
1.7

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Vitro, S.A.B. de C.V. Dividends
Year Dividends Growth
2000 1
2001 1 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2015 2 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2021 0 0%
2022 0 0%

Vitro, S.A.B. de C.V. Profile

About Vitro, S.A.B. de C.V.

Vitro, S.A.B. de C.V., through its subsidiaries, manufactures, processes, distributes, and sells a range of glass products worldwide. It operates in Flat Glass, Chemicals, and Containers segments. The company provides flat glass products for the construction and automotive industries in the original and replacement equipment markets; and produces inorganic chemicals, such as sodium carbonate, sodium bicarbonate, sodium chloride, and calcium chloride for use in the glass, detergent, water treatment, pharmaceutical, food for human consumption, oil industry, and road de-icing markets, as well as in the livestock sector and others. It also offers glass containers to the cosmetic, fragrance, toiletry, pharmaceutical, and liquor markets, as well as provides engineering, equipment, and automation services for various sectors. Further, it develops molds, machineries, equipment, and capital goods for use in the glass container industry. The company also provides automotive glass products, and replacement glass distribution and installation services; and architecture glass products for buildings and homes. Vitro, S.A.B. de C.V. was founded in 1909 and is based in San Pedro Garza García, Mexico.

CEO
Mr. Adrian G. Sada Cueva
Employee
1.401
Address
Avenida Ricardo MargAin Zozaya No. 400
San Pedro Garza García, 66265

Vitro, S.A.B. de C.V. Executives & BODs

Vitro, S.A.B. de C.V. Executives & BODs
# Name Age
1 Shlomo Frymerman
President of Vitro Glass Containers
70
2 Carlos Mario Bernal Galvez
President of Vitro Automotive Glass
70
3 Mr. Claudio Luis Del Valle Cabello
Chief Financial & Administrative and General Director of Administration & Finance
70
4 Mr. Alejandro Francisco Sánchez Mújica
Secretary of the Board
70
5 Mr. Adrian G. Sada Cueva
Executive Chief Executive Officer, President of Vitro Diverse Industries & Director
70
6 Adrián Meouchi
Vice President of Investor Relations
70
7 Javier Arechavaleta Santos
Legal Counsel
70
8 Alfonso Gomez Tamez
CHRO and Continuous Improvement
70

Vitro, S.A.B. de C.V. Competitors